Thursday, August 27, 2026 at 12:00 PM
August 27th, 2026 1.00 AMA PRA Category 1 Credit™ Hours
Description
Fouad Chebib, MD, FASN, Mayo Clinic
Dates and Times
Start: 8/27/2026 12:00 PM
End: 8/27/2026 1:00 PM
Objectives
1. Recognize ADPKD as a systemic disorder and identify its major kidney and extrarenal manifestations.
2. Apply a practical, individualized approach to ADPKD care, including diagnosis, prognostic risk assessment, multidisciplinary management, and selection of appropriate patients for tolvaptan therapy.
3. Describe the evolving therapeutic landscape of ADPKD, including clinical-trial opportunities, emerging biomarkers, artificial-intelligence applications, and novel disease-modifying therapies.
Speakers
Location
DHLRI 170
473 W 12th Ave
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Maggie Murray
Department: Internal Medicine
Phone: (614) 293-3989
Email: Maggie.Murray@osumc.edu